期刊文献+

Ghrelin对糖尿病大鼠心肌动作电位和瞬时外向钾电流的影响 被引量:2

Effects of ghrelin on action potential and transient outward potasium current in streptozotocin-induced diabetic cardiomyopathy rats
下载PDF
导出
摘要 目的探讨外源性ghrelin对糖尿病心肌病(DCM)大鼠心肌动作电位及瞬时外向钾电流(Ito)的影响。方法雄性SD大鼠腹腔注射链脲佐菌素(60mg/kg)诱导Ⅰ型DCM模型,并采用全细胞膜片钳技术观察ghrelin对糖尿病大鼠心室肌细胞动作电位及瞬时外向钾电流的影响。结果与DCM组比较,10^(-7) mmol/L ghrelin明显延长DCM大鼠心室肌细胞5%动作电位时程(APD50)[(12.49±2.32)%;n=7,P=0.037]及APD90[(26.29±5.13)%;n=7,P=0.006];并明显抑制Ito电流峰值,抑制率[(23.14±3.07)%;n=9,P=0.021]。结论外源性ghrelin抑制Ito电流而延长DCM大鼠心肌动作电位时程,参与糖尿病大鼠心脏电生理的重构。 Objective To study the effects of ghrelin on action potential (AP) and transient outside K^+ current (I,o) in ventricular myocytes of diabetic cardiomyopathy (DCM) rats. Methods A rat model of DCM was established by single intraperitoneal injection of streptozotocin (STZ, 60 mg/kg), and whole cell patch-clamp technique was used to record the effects of 10.7 mmol/L ghrelin on AP and /to current density in the DCM rat ventricular myocytes. Results Compared to DCM group, Ghrelin of 10.7 mmol/L could significantly prolong APDs0[(12.49±2.32)%; n=7, P=0.037] and APD90[(26.29±5.13)%; n=7, P=0.006] and decrease /to current peak value [(23. 14± 3.07)% ; n = 9, P= 0. 021] in DCM rat ventricular myocytes. Conclusion Exogenous ghrelin is involved in the electrophysiological reconstruction of the heart of diabetic rats by decreasing /to current and prolonging APD in STZ-induced DCM rat ventricular myocytes.
作者 冯丹阳 孙强 陈莉娜 赵正杭 周筠 FENG Da n-yang SUN Qiang CHEN Li-na ZHAO Zheng-hang ZHOU Jun(Department of Pharmacology, School of Basic Medical Sciences of Xi'an Jiaotong University Health Science Center, Xi'an 710061 Department of Pharmacy, Xi'an Electric Central Hospital, Xi'an 710032, China)
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2017年第5期661-664,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金面上项目(No.81170176) 陕西省科技统筹创新工程计划项目(No.2014KTCL03-10)~~
关键词 GHRELIN 糖尿病心肌病 动作电位 瞬时外向钾电流 ghrelin diabetic cardiomyopathy action potential transient outside potassium current
  • 相关文献

参考文献3

二级参考文献81

  • 1BOWERS CY, MOMANY F, REYNOLDS GA, et al. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro [J]. Endocrinology, 1980, 106:663-667. 被引量:1
  • 2GUILLEMIN R, BRAZEAU P, BOHLEN P, et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly [J]. Science, 1982, 218:585-587. 被引量:1
  • 3HOWARD AD, FEIGHNER SD, CULLY DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release [J]. Science, 1996, 273:974-977. 被引量:1
  • 4DAVENPORT AP, BONNER TI, FOORD SM, et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function [J]. Pharmacol Rev, 2005, 57:541-546. 被引量:1
  • 5KOJIMA M, HOSODA H, DATE Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J]. Nature, 1999, 402:656-660. 被引量:1
  • 6LEITE-MOREIRA AF, SOARES JB. Physiological, pathological and potential therapeutic roles of ghrelin [J]. Drug Discov Today, 2007, 12:276-288. 被引量:1
  • 7MALAGON MM, LUQUE RM, RUIZ-GUERRERO E, et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes [J]. Endocrinology, 2003, 144:5372-5380. 被引量:1
  • 8HOSODA H, KOJIMA M, KANGAWA K. Biological, physiological, and pharmacological aspects of ghrelin [J]. J Pharmacol Sci, 2006, 100:398-410. 被引量:1
  • 9CAO JM, ONG H, CHEN C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system [J]. Trends Endocrinol Metab, 2006, 17:13-18. 被引量:1
  • 10MUCCIOLI G, BARAGLI A, GRANATA R, et al. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors [J]. Neuroendocrinology, 2007, 86:147-164. 被引量:1

共引文献9

同被引文献13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部